New ivermectin study shows 92% lower chance of COVID death

[WHO IS SERAFIN]

How many died because of the left and their ties with pharma because they didn’t want a cheap effective drug to be used!!

Quote:

Protection increases with increased usage of politically charged drug​

Art Moore
WND News Center

A large study on the impact of using ivermectin as a prophylaxis for COVID-19 found that regular users of the drug experienced up to a 92% reduction in mortality compared to those who did not.

Brazilian research scientist Dr. Flavio A. Cadegiani said via Twitter that his studyin his home country showed a “dose-response effect,” meaning that “the more you used, the more protection you had.”

He observed that people who use ivermectin regularly every 15 days for at least six to eight weeks had up to a 92% reduction in mortality.

Cadegiani conducted a previous study of drug that evaluated whether its use could impact COVID-19 infection and mortality rates.

New ivermectin study shows 92% lower chance of COVID death

A large study on the impact of using ivermectin as a prophylaxis for COVID-19 found that regular users of the drug experienced up to a 92% reduction in mortality compared to those who did not.

www.clarkcountytoday.com

 

[Webster]

Are we still flogging that dead horse?

Study Finds No Benefit to Taking Ivermectin for COVID-19 Symptoms

DURHAM, N.C. – A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no differences in relief of mild-to-moderate COVID-19 symptoms between participants taking ivermectin and participants taking a placebo.

corporate.dukehealth.org

DURHAM, N.C. – A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no differences in relief of mild-to-moderate COVID-19 symptoms between participants taking ivermectin and participants taking a placebo.

“There was no significant benefit in our primary endpoint of resolution of symptoms in mild-to-moderate COVID-19 illness,” said Adrian Hernandez, M.D., the study’s administrative principal investigator and executive director of the DCRI. “Overall, most people improved their symptoms whether they took ivermectin or not. Given these results, there does not appear to be a role for ivermectin outside of a clinical trial setting, especially considering other available options with proven reduction in hospitalizations and death.”

There was also no difference observed in the number of hospitalizations or emergency room visits. Findings appear on medRxiv, a pre-publication server, and have been submitted to a peer-reviewed journal.

 

[WHO IS SERAFIN]

Are we still flogging that dead horse?

Study Finds No Benefit to Taking Ivermectin for COVID-19 Symptoms

DURHAM, N.C. – A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no differences in relief of mild-to-moderate COVID-19 symptoms between participants taking ivermectin and participants taking a placebo.

corporate.dukehealth.org

But yet the study shows 93% effectiveness despite you showing a political outdated article paid for by big pharma.

It’s effective and it saved tens of thousands in South America because they used it.

 

[Webster]

It’s effective and it saved tens of thousands in South America because they used it.

So what?

 

[DrLeftover]

I'll add one thing to this, and by extension, to the rest of these sorts of debates where neither side will ever be convinced no matter what evidence is trotted out and run up the flagpole....

 

[WHO IS SERAFIN]

So what?

So why do you like big pharma that sacrificed lives for profit with this effective drug.